TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region. They are committed to delivering minimally invasive surgical technologies that enhance patient clinical care while providing sustained value for their customers.
Current Team (6)Update
|Apr 6, 2016||Yahoo Finance - TranS1 Names Brandon Arthurs, Vice President of Research & Development|
|Mar 14, 2016||odtmag.com - Fusing Innovation to the Spinal Sector|
|Mar 13, 2016||beckersspine.com - AxiaLIF's value-based advantage: Key thoughts on TranS1's spinal technology Featured|
|Feb 26, 2016||medicaldesignandoutsourcing.com - TranS1 CEO discusses recent economic analysis and the benefits of AxiaLIF|
|Feb 19, 2016||Denver Post - People on the move, 2/12/2016|
|Jan 20, 2016||PRNewswire UK All - SI-BONE, Inc. Announces European Expansion with Formation of SI-BONE UK Ltd and Key Additions to Management Team|
|Nov 23, 2015||Xconomy - Novozymes, TranS1, Symberix, & More in NC Innovation News|
|Nov 10, 2015||Business Wire - Economic Analysis Demonstrates Substantial Spine Surgery Cost Savings with TranS1 AxiaLIF|
Quandary Medical LLC
1518 Blake St.
Denver, Colorado 80202